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Maya Ghoussaini (1) , Vincent Vatin (1) , Cécile Lecoeur (1) , Victor Abkevich (2) , Adib Younus (2) , Chantal Samson (1) , Christophe Wachter (1) , Barbara Heude (3) , Maïté Tauber (4) , Patrick Tounian (5) , Serge Hercberg (6) , Jacques Weill (7) , Claire Levy-Marchal (8) , Catherine Le Stunff (9) , Pierre Bougnères (9) , Philippe Froguel (1, 10) , David Meyre (1) . 2 Abstract Context: The Melanin Concentrating Hormone Receptor 2 (MCHR2) is a G protein-coupled receptor for MCH, a neuropeptide that plays important role in feeding behaviors. MCHR2 maps on chromosome 6q16.3, in a susceptibility locus for childhood obesity. Objective: The aim of this study was to investigate the association between MCHR2 variation and human obesity. Design: Case control and family-based studies were performed. Participants: 141 obese children and 24 non-obese adult subjects were sequenced and case-control analyses were conducted using 628 severely obese children and 1,401 controls. Results: Eleven Single Nucleotide Polymorphisms (SNPs) were identified. We showed nominal association between children of the at risk T allele (59.0%, p=0.01), especially in children with most severe forms of obesity (Zscore of BMI>4) (67.0%, p=0.003). The A76A at risk T allele was also associated with overeating during meal (p=0.02) in an additional group of 102 non-obese children. None of MCHR2 variants, including the A76A SNP, showed association with adult severe obesity, although a trend for association of the T allele of this variant with food disinhibition (p=0.06) and higher hunger (p=0.09) was found. This variant was not associated with childhood obesity in an independent case-control study including 1,573 subjects (p=0.98). Moreover, the A76A SNP did not explain the linkage on the 6q locus. Conclusions:
Our results altogether suggest that MCHR2 is not a major contributor to polygenic obesity and support a modest effect of the A76A SNP on food intake abnormalities in childhood.
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If the current epidemic of obesity clearly reflects the environmental and behavior changes during the past half-century, genetic background remains important especially in the severe forms of obesity, as assessed by ethnic (1), familial (2, 3) or linkage (4) studies. We previously identified in the French population, a linkage with childhood obesity on chromosome 6q16.3-q24.2 with a Lod score of 4.06 (5) . Recently, we reported that variation in ENPP1 (Ectonucleotide Pyrophosphatase Phosphodiesterase1) partly contributed to the observed linkage (6) . Indeed, if we remove the 15 affected sibling pairs from a total of 135 sibling pairs sharing the ENPP1 at risk haplotype, the Multipoint Lod Score drops from 4.06 to 1.6 at marker D6S287 and a new maximal score of 2.63 is obtained 16 Mb centromeric to the original linkage peak, at marker D6S301 (6).
MCHR2 is an obvious candidate gene lying under this new peak. The orphan G-coupled protein Melanin-Concentrating Hormone Receptor 2 (MCHR2) consists in 340 amino acids with a coding sequence distributed over 6 exons (7) (8) (9) and showing 38% homology with the Melanin-Concentrating Hormone Receptor 1 (MCHR1) (10) . MCHR2 displays high-affinity binding to MCH (11) , which is known to increase food intake and body weight in rodents after its central administration (12) (13) (14) . MCH acts as a functional antagonist of the α-MSH (alpha-Melanocyte-Stimulating Hormone), in a complex central network involving the melanocortin pathways (15) . MCH overexpression leads to obesity and insulin resistance in mice (16) . In contrast, mice that lack the MCH gene or targeted inactivation of MCH gene in neurons cause a phenotype of leanness as a consequence of hypophagia and increased metabolic rate (17) . Expression of MCHR2 is restricted to several regions in the brain, including the arcuate nucleus and the ventral medial nucleus, areas involved in regulation of food intake (18) . Consistently, these two nucleus have been recently implicated in mediating the MCH effect via activation or inhibition of feeding circuits (19).
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Tan et al. showed that functional expression of the MCHR2 gene is not conserved during the evolution. In contrast to MCHR1, the functional MCHR2 is only expressed in humans, primates and carnivores but not in rodents (10) . Thus, little is known about the physiological role of MCHR2 and human genetics offers unique opportunity to evaluate the contribution of this receptor to appetite regulation and associated diseases in humans. This paper investigates the implication of variation in MCHR2 in polygenic and monogenic forms of childhood obesity and its related quantitative and eating disorders traits.
RESEARCH DESIGN AND METHODS
Population used for association studies
Association studies with childhood and adulthood obesity were performed for variants with Minor Allele Frequency (MAF) ≥ 5% using a set of 628 unrelated obese children chosen from kg/m 2 ). The study protocol was approved by all local ethic committees and an informed consent was obtained from each subject before participating in the study.
Obese children cohort
The pool of obese children used for case/control analysis was constituted of a first set of 424 unrelated obese children collected from 424 pedigrees with at least one obese child at the CNRS -UMR8090 Unit in Lille, and at the Jeanne de Flandres Hospital in Lille, a second set of 93 unrelated obese children recruited at the Children's Hospital, Toulouse, a third set of 24 unrelated obese children recruited through the "Fleurbaix-Laventie Ville Santé" study and a fourth set of 87 unrelated children collected from the Trousseau Hospital. We genotyped the A76A T/C SNP in 148 additional obese children collected at the CNRS UMR8090 and in 439 obese children collected at the Saint Vincent de Paul hospital. Children with a BMI greater than the 97 th percentile for age and sex reported on the tables of Rolland-Cachera et al. (20) (French general population) were defined as obese as recommended by the European Childhood Obesity Group (ECOG) (21).
Obese adults cohort
The class III obese adult subgroup was constituted by 696 class III obese adults collected at 
Control adults cohort
The same adult control group was used for both association studies in obese children and adults as this group had a longer environmental exposure and still remains non obese. This group consisted in 1,401 nonobese (BMI < 27 kg/m²) normoglycemic (fasting glycemia < 5.56 mmol/l) French Caucasian adults pooled from four separate studies; 360 unrelated nonobese and nondiabetic subjects were recruited at the CNRS-Institut Pasteur Unit in Lille, 235 were recruited by the "Fleurbaix-Laventie Ville Santé" study (22) , 396 from the HAGUENEAU study (23) and 410 from the SUVIMAX study (24). Absence of stratification among all the different studied cohorts was verified using 26 neutral polymorphic markers disseminated across the genome (data not shown). We genotyped the A76A T/C SNP in 986 additional lean adult subjects (BMI < 27 kg/m²) issued from the SUVIMAX cohort. The genetic study was approved by the ethical committee's of Hôtel Dieu Hospital in Paris and
Centre Hospitalier Régional Universitaire de Lille.
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We used 424 pedigrees with childhood obesity (645 childhood obesity trios -two parents and one obese child) and 102 non obese childhood trios (BMI < 97 th percentile for gender and age) and 158 pedigrees with adulthood obesity including 514 individuals (303 obese, 72 overweight and 139 lean) for Transmission Disequilibrium Test (TDT) analysis for obesity status and eating behavior traits.
Eating behavior traits
Food behavior in obese adults was assessed by the TFEQ (Three Factor Eating Questionnaire) (25), which evaluates the cognitive restraint of eating, disinhibition, and hunger. Scores for the TFEQ were available for 500 class III obese patients with familial history of obesity.
Because the TFEQ is not a validated questionnaire in children, food intake behavior in 102 young non obese children (46 girls and 56 boys; BMI < 97 th percentile for gender and age)
was assessed by an in-house questionnaire administrated by a trained physician. Seven questions were asked. Two questions were related to food intake behavior during a meal (presence or absence of hyperphagia and rapidity of food ingestion) and between meals (presence or absence of snacking).
Sequencing and genotyping
The screening of the MCHR2 gene was done using overlapping PCR fragments that cover all exons of the MCHR2 gene, exon/intron junctions, and a part of the putative promoter and the 
3'UTR (UnTranslated Region
)
Statistical analysis
Tests for deviation from Hardy-Weinberg Equilibrium (HWE) and for association were performed with the De Finetti program (http://ihg.gsf.de/cgi-bin/hw/hwa1.pl). All SNPs were in HWE. We compared all cases against all control individuals as well as class III obese adults and obese children separately against the control group. These analyses were done by comparing allelic frequencies of the SNPs between cases and controls. Analysis of variance and T-test were performed for the studying of quantitative traits in obese and control adults.
Haplotype frequencies were determined and were compared between groups with the UNPHASED software http://www.mrc-bsu.cam.ac.uk/personal/frank/. Familial analysis on binary and quantitative traits were performed by the TDTPHASE and QPDTPHASE methods implemented in the UNPHASED software. In order to evaluate the effect of the T at risk 8 allele of the A76A variant on linkage, we used the Genotype IBD Sharing Test (GIST) procedure. SPSS 10.1 software was used for general statistical analysis.
Results
Screening of the gene
All exons of the MCHR2 gene, exon/intron junctions, 870 bp of the putative promoter and 1,095 bp in the 3'UTR were sequenced in 47 obese children from families with evidence for linkage of childhood obesity to 6q, 94 obese children with early obesity onset (Z score of BMI>4.5, obesity onset before 5 years old), and in 24 non obese normoglycemic adults. We identified six SNPs in the promoter region, one non synonymous mutation, two synonymous mutations and two SNPs in the 3' UTR ( Figure 1 and 2 ). Among these SNPs, three were frequent (-38,245 ATG A/G, -38,244 ATG T/C and A76A T/C) with minor allele frequencies > 5% and Linkage Disequilibrium analysis (LD) showed that these SNPs were in incomplete LD (R 2 <0.8). Therefore, the three SNPs were selected to be typed in all our samples (Appendix Figure 1) . The eight remaining rare variants including the non synonymous variant R152Q G/A (minor allele frequencies < 5%, Table1) were found in both obese and control subjects. These results ruled out a potential implication of these variants in monogenic forms of obesity in our studied population. Table 2 ). The remaining SNP -38,244 ATG T/C was not associated with childhood obesity (p=0.50, Table 2 ).
Association studies of frequent SNPs with childhood obesity
Because our initial screening did not include intronic regions, we analyzed data concerning nine additional tagged SNPs covering the MCHR2 introns, that were included in a WholeGenome Association scan of childhood obesity performed in a subset of of obese children cohort (325 obese children compared to 425 control subjects, unpublished results). The location of the intronic SNPs is shown in Figure 1 .
No intronic SNP showed significant (p<0.05) association with childhood obesity, except for SNP -26,780 ATG C/T (rs9496085, p=0.035), located in intron 1 of MCHR2. We then genotyped rs9496085 in our extended case control set of 2,029 French Caucasians. This SNP showed only a modest trend toward association with childhood obesity (p=0.055, 95% CI=
[0.75-1.00], OR=0.87; Table 2 ).
TDT analysis in trios with childhood obesity
TDT analysis of 424 pedigrees with childhood obesity was then performed for the two In an attempt to gain statistical power in our analysis, we then took into account the phenotypes and genotypes of three available generations (children, parents and grand parents)
for the obesity threshold (97 th percentile) for gender and age. We analyzed together the overtransmission of the at risk allele from the heterozygous grand parents to the obese parents and the over-transmission of the at risk allele from the heterozygous parents to the obese children.
An over-transmission of the "at risk allele" to obese offspring's was found (61.0%, p=0.002,).
To investigate if the A76A variant could affect primarily eating behaviors and thus induce obesity, we restricted the TDT analysis of eating behavior phenotypes to a subgroup of 102 non-obese children , given that the T allele was over-transmitted to obese children. These non-obese children were issued from the initial 424 pedigrees with childhood obesity and showed no distortion of segregation for the T allele (53.8%, p=0.69). Interestingly, the analysis of non-obese children with overeating during meal showed a systematic transmission of the T allele to these subjects (100%, p=0.004, 6 transmitted versus 0 non transmitted).
Accordingly, 25% of the TT genotype carriers of the A76A variant showed overeating during meal, whereas none of the TC and CC genotype carriers harbored this disorder (p=0.02).
Association studies with adulthood obesity
No association with adult class III obesity was found for any of the four SNPs (Table 2) . Table   2 ). In adults there was also a trend toward association of the T allele of the A76A variant with higher hunger (p=0.09) and with disinhibition for food (p=0.06, data not shown).
Haplotype analysis
To estimate the potential effect of the combination of the MCHR2 SNPs, we performed haplotype analysis in obese subjects and controls using the UNPHASED software. The haplotype including the two associated SNPs or the four frequent SNPs did not provide stronger evidence for association than SNPs analyzed independently (data not shown).
Linkage analysis
After exclusion of subjects carrying at least one risk haplotype of the ENPP1 gene, we tested the contribution of the -38,245 A/G and A76A T/C SNPs to the maximum of the linkage peak at marker D6S301 using GIST procedure. Our results did not provide any evidence for participation of this SNP to the linkage observed on the 6q locus (dominant model, p=0.16).
Replication study between A76A T/C and childhood obesity
In an attempt to replicate the association of the A76A T/C in an independent French cohort, we genotyped this polymorphism in two additional sets including 986 lean adult subjects issued from the SUVIMAX cohort, and 587 obese children collected at the CNRS UMR8090 
Discussion
This study is the first to investigate a possible role of MCHR2 SNPs in human polygenic severe obesity in a large population of French Caucasians. The initial case/control analysis gave nominal evidence for association between the two variants -38,245 A/G and A76A T/C and childhood obesity but this result does not resist to multiple testing correction. Even if the TDT analysis supports the contribution of the A76A T/C SNP to childhood obesity, it is noteworthy to indicate that none of these two variants showed association with severe forms of obesity in adults. We were not able to replicate the association between A76A T/C SNP and childhood obesity in an independent case control design including 1,573 subjects.
Moreover, our results did not provide any evidence for participation of these variants to the linkage observed on the 6q locus. This underlines the need to carry on the search for other genetic variants contributing to the observed linkage with childhood obesity on chromosome 6q.
Our data suggests that the A76A T/C MCHR2 SNP may mediate modest eating behavior disorders in childhood such as overeating during meals. However, this result should be interpreted with caution because we used a non-validated in-house questionnaire in children.
We also found a trend for an effect of this SNP on food intake parameters in adults. The impact of genetic variants of the MCHR2 gene on food intake, if any, seems to be attenuated in adulthood, which could explain the lack of association of the A76A variant in severe adult obesity. Similar observations have been found for other key components of the central regulation of food intake. Farooqi et al. showed an age-related decrease in hyperphagia in obese subjects with MC4R mutations, that seems to occur with adulthood (27).
The observation that genetic variation in MCHR2 could modulate food intake is consistent with the proposed role of MCH/MCH receptor pathway in the literature (11) . As MCHR1, gene. Unfortunately, this SNP was not genotyped in the Hapmap II avoiding us to study the extensive LD with A76A in the 6q16 region. A detailed analysis of linkage disequilibrium in the MCHR2 region by sequencing of large size population-based cohorts could be useful. If LD analysis and association studies revealed that the A76A variant is itself a primary variant determining obesity susceptibility, then functional analysis should be undertaken.
In our study, the eight rare SNPs have been found in both obese and control individuals. This lack of implication of rare variants of the MCHR2 gene in monogenic forms of obesity in our studied population is consistent with the findings of Bell et al. for the MCHR1 gene (32). A previous study performed in the United Kingdom population found two non coding SNPs in the MCHR2 gene, which were not analyzed as they were rare (33). Screening of this gene in white and African-American individuals identified four non coding SNPs and four coding mutations (34) that include the three coding mutations identified in our study. A fourth non synonymous mutation R63K was identified and was not detected in our initial sequenced set.
Functional analysis of MCHR2-carrying each of the non synonymous mutations G152Q or R63Q demonstrated that this receptor binds MCH and couples to intracellular signalling pathways in a similar way to wild type MCHR2 (34). The absence of functional effect particularly of the MCHR2-carrying G152Q mutation is consistent with our findings. This SNP was found in obese and control subjects at equal frequencies.
In conclusion, our results suggest that MCHR2 gene is not a major contributor to polygenic and monogenic forms of childhood and adulthood obesity. However, the A76A T/C SNP of MCHR2 might have a modest effect on food intake abnormalities. These preliminary results need to be confirmed in additional populations. 
